GLP-1 Microdosing

How to Microdose Semaglutide (The Only Honest Answer)

The number you are searching for cannot come from an article. Here is why - and what to do instead.

6 min read·Sources: FDA prescribing information, peer-reviewed trials and NIH literature·Updated August 2026·Educational content, not medical advice
The short answer

There is no published microdose regimen for semaglutide, and no article can safely give you a number. Dosing comes from the clinician who prescribes for you and from the label on the medication you are dispensed. Compounded medications are not FDA-approved. Searching for a dose online is the single most common way people get hurt.

See your price Takes about 10 minutes · a clinician can decline · full refund if not prescribed
A small droplet on a needle tip above a partially lit receptor field

Why no number appears here

A dose depends on your history, your other medications, your response, and the concentration of the specific preparation dispensed to you. Two vials labelled the same strength can require different volumes. That is why the number lives on your label, not in a blog post.

What your label governs

FDA prescribing information and your dispensed instructions are the authority on your dose, timing, and titration. If those two disagree with anything you read online, follow the label and call your clinician.

Units versus milligrams

Most dosing errors we see come from confusing syringe units with milligrams. They are not the same scale. If your instructions and your syringe do not obviously agree, stop and ask before injecting.

Trial results belong to the specific FDA-approved product studied, at the doses studied.

NEJM, SURMOUNT-1 ↗

What to ask instead

Bring the real questions to your visit: what dose am I starting at, when would you change it, what should I do if I miss a week, and what would make you stop treatment. Those answers are specific to you.

Where PinwellRx fits

Our role is the process, not the prescribing. You complete an intake, an independent licensed clinician reviews it and decides whether treatment is appropriate, and a licensed U.S. pharmacy dispenses what is prescribed. See the 30-second film answers for this medication.

What a titration schedule is actually for

Titration means starting at a dose below the one intended to be effective and stepping up on a schedule. It exists for tolerability, not caution for its own sake. Receptor signalling that arrives gradually gives the gut time to adapt, which is why the label sets minimum intervals between increases rather than leaving the pace open. Skipping ahead does not accelerate anything except side effects. Holding at a dose is a legitimate clinical decision, and so is stepping back down. If you want the lower end of that range as a deliberate plan rather than a waypoint, that is what microdosing describes. Your clinician sets the schedule, reviews how you are tolerating it, and adjusts. Nothing about a titration plan guarantees a particular result, and no schedule substitutes for the follow-up conversation that decides whether to continue.

A compounded preparation is not a generic of, or equivalent to, any FDA-approved product.

FDA, human drug compounding ↗

How semaglutide works on the GLP-1 receptor

Semaglutide is a GLP-1 receptor agonist. GLP-1 is an incretin hormone your intestine releases after eating; it prompts insulin release when glucose is elevated, slows gastric emptying, and signals satiety in the hypothalamus. Semaglutide binds the same receptor, and structural modifications give it a long half-life, which is what makes once-weekly dosing possible for the injectable form. It acts on one receptor rather than two, which is the pharmacological difference from tirzepatide. According to the FDA prescribing information for semaglutide products, that mechanism is the basis of the approved indications. Oral semaglutide reaches the same receptor by a different route and carries strict dosing conditions as a result, which oral versus injectable semaglutide covers. Whether any form suits you is decided by a licensed clinician after an evaluation.

What compounded means, and what it does not

A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as STEP-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.

Why side effects are mostly digestive, and mostly early

Because the receptors semaglutide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for semaglutide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.

You have been putting this off.

Most people finish the intake in one sitting. A clinician can still say no.

Take the first stepTakes about 10 minutes · a clinician can decline · full refund if not prescribed

Frequently asked questions

Can you just tell me a starting microdose?

No. Publishing a dose for a compounded medication we do not know the concentration of, for a patient we have not evaluated, would be unsafe and inappropriate.

Where do I find my dose?

On the label of the medication dispensed to you, and in the instructions from your prescribing clinician.

What if a forum lists a schedule?

Treat it as unverified. Concentrations differ between preparations, so a volume that is right for one vial can be wrong for another.

Is microdosing an approved regimen?

No. It is not an FDA-approved dosing schedule, and compounded medications are not FDA-approved.

How do I inject semaglutide?

Follow the instructions supplied with your specific preparation. Weekly peptide injections are generally subcutaneous, into the abdomen away from the navel, the outer thigh, or the back of the upper arm, rotating the site each week. Contact the pharmacy before injecting if anything about your dose or volume is unclear.

Where do you inject semaglutide?

Subcutaneous sites are the abdomen, outer thigh, and back of the upper arm. Rotating between them reduces local irritation. Your dispensing pharmacy provides site guidance for your preparation.

Get your dose from a clinician, not a forum

A licensed clinician reviews your history and prescribes only if it is appropriate. About 10 minutes.

Takes about 10 minutes · a clinician can decline · full refund if not prescribed

Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.

Sources

Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.

  1. FDAFDA prescribing information, semaglutide (DailyMed)
  2. FDAFDA. Compounding and the FDA: questions and answers
  3. FDA databaseDrugs@FDA: search approved labeling for semaglutide
  4. Peer-reviewedSTEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM 2021)

Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.

More on GLP-1 Microdosing

Same medication, different question.

See your price